Discover 3,012 paid clinical trials in Riverside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,012
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: La Palma CA, Newport Beach CA, Long Beach CA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase 3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Long Beach CA, Los Angeles CA, Northridge CA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase 3, Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Los Angeles CA, Stanford CA, San Francisco CA,
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06947928
Phase 2, Phase 3, Recruiting
Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy
for
Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8
Location: Duarte CA, Columbus OH
Sponsor: City of Hope Medical Center
Sex: All
Age: 60+
Code: NCT06139627
Recruiting
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
for
Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer,
Location: Los Angeles CA, La Jolla CA, Houston TX, Minneapolis MN,
Sponsor: Fate Therapeutics
Sex: All
Age: 18+
Code: NCT07216105
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
for
Mantle Cell Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06054776
Phase 2, Recruiting
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: Duarte CA, Los Angeles CA, San Francisco CA, Houston TX,
Sponsor: EvolveImmune United, Inc
Sex: All
Age: 18+
Code: NCT07217171
Phase 1, Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
for
Autoimmune Haemolytic Anaemia
Location: Duarte CA, Los Alamitos CA, Los Angeles CA, Torrance CA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07086976
Phase 3, Recruiting
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
for
Cutaneous Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT04670874
Recruiting
Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy
Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment
Location: Torrance CA, Richmond IN, Midland MI, Baltimore MD,
Sponsor: Abcentra
Sex: All
Age: 18+
Code: NCT06927739
Phase 2, Recruiting
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
for
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Location: Duarte CA, Stanford CA, Seattle WA, Kansas City KS,
Sponsor: PeproMene Bio, Inc.
Sex: All
Age: 18+
Code: NCT05370430
Phase 1, Recruiting
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for
Geographic Atrophy
Location: Torrance CA, Beverly Hills CA, Encino CA, Peoria AZ,
Sponsor: Sanofi
Sex: All
Age: 60+
Code: NCT07215234
Phase 1, Phase 2, Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Glendale CA, Long Beach CA, Los Angeles CA, Aurora CO,